Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

abiraterone acetate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

CYP17A1 inhibitor

Related drugs:

‹

abiraterone/niraparib (2)

abiraterone/niraparib (2)

›

No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate Sensitive: A1 - Approval abiraterone acetate Sensitive : A1	abiraterone acetate Sensitive: A1 - Approval abiraterone acetate Sensitive : A1
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2	abiraterone acetate Resistant: A2 - Guideline abiraterone acetate Resistant : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + degarelix Sensitive: A2 - Guideline abiraterone acetate + degarelix Sensitive : A2	abiraterone acetate + degarelix Sensitive: A2 - Guideline abiraterone acetate + degarelix Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + triptorelin Sensitive: A2 - Guideline abiraterone acetate + triptorelin Sensitive : A2	abiraterone acetate + triptorelin Sensitive: A2 - Guideline abiraterone acetate + triptorelin Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2	abiraterone acetate + leuprolide acetate Sensitive: A2 - Guideline abiraterone acetate + leuprolide acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + histrelin acetate Sensitive: A2 - Guideline abiraterone acetate + histrelin acetate Sensitive : A2	abiraterone acetate + histrelin acetate Sensitive: A2 - Guideline abiraterone acetate + histrelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + dexamethasone Sensitive: A2 - Guideline abiraterone acetate + dexamethasone Sensitive : A2	abiraterone acetate + dexamethasone Sensitive: A2 - Guideline abiraterone acetate + dexamethasone Sensitive : A2
AR amplification	Prostate Cancer	AR amplification	Prostate Cancer	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B
TP53 deletion	Prostate Cancer	TP53 deletion	Prostate Cancer	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B
RB1 deletion	Prostate Cancer	RB1 deletion	Prostate Cancer	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B	abiraterone acetate Resistant: B - Late Trials abiraterone acetate Resistant : B
BRCA2 deletion	Prostate Cancer	BRCA2 deletion	Prostate Cancer	abiraterone acetate Sensitive: B - Late Trials abiraterone acetate Sensitive : B	abiraterone acetate Sensitive: B - Late Trials abiraterone acetate Sensitive : B